Clinical trials conducted amid an Ebola epidemic in the Democratic Republic of Congo (DRC) have identified two new drugs that can dramatically cut mortality from the disease.Ebola is a viral hemorrhagicĀ fever that kills up to 90% of those it infects. The latest outbreak, in the Democratic Republic of Congo (DRC), has so far killed nearly 1,900 people.